Pancreatic Cancer Research

ResearcherCity of HopeActive in the last 2 years

Kun‐Yu Teng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1315-3247; OpenAlex author ID A5102945409. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Off-the-shelf invariant NKT cells expressing anti-PSCA CAR and IL-15 promote pancreatic cancer regression in mice. Co-author DOI 10.1172/jci179014↗
  2. Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2021.12.281↗
  3. B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer. First author DOI 10.3389/fonc.2022.814312↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianhua Yu · 3 shared papers, 2022–2025 · strength 0.48
  2. Zhenyu Dai · 2 shared papers, 2022–2025 · strength 0.35
  3. Zheng Gang Zhu · 2 shared papers, 2022 · strength 0.24
  4. Li-Shu Wang · 1 shared paper, 2025 · strength 0.24
  5. Laleh Golkar Melstrom · 1 shared paper, 2025 · strength 0.24
  6. Dechun Li · 1 shared paper, 2022 · strength 0.11
  7. Xin Zhao · 1 shared paper, 2022 · strength 0.11
  8. Songbing He · 1 shared paper, 2022 · strength 0.11
  9. Yunyun Xu · 1 shared paper, 2022 · strength 0.11
  10. Vincent M. Chung · 1 shared paper, 2022 · strength 0.11
  11. Jian Zhou · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.